Harvey I Pass Selected Research

1-methyl-1-piperidinomethane sulfonate

11/2015	DNA copy number gains in malignant pleural mesothelioma.
9/2011	Telomerase activity in pleural malignant mesotheliomas.
10/2009	Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.
2/2004	Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harvey I Pass Research Topics

Disease

111	Neoplasms (Cancer) 01/2022 - 02/2002
73	Malignant Mesothelioma 09/2021 - 02/2002
58	Mesothelioma 01/2022 - 02/2002
32	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2003
18	Carcinogenesis 11/2021 - 12/2004
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2003
13	Inflammation (Inflammations) 09/2021 - 07/2010
10	Neoplasm Metastasis (Metastasis) 11/2019 - 02/2002
9	Adenocarcinoma of Lung 01/2021 - 01/2006
7	Breast Neoplasms (Breast Cancer) 10/2018 - 06/2003
6	Adenocarcinoma 01/2021 - 02/2005
5	Infections 01/2021 - 02/2002
5	Pleural Effusion (Pleural Effusions) 10/2018 - 01/2008
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018 - 01/2018
2	Malignant Pleural Effusion 01/2018 - 01/2016
2	Wilms Tumor (Wilm's Tumor) 01/2017 - 09/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2016 - 01/2006
2	Carcinoma (Carcinomatosis) 09/2016 - 09/2013
2	Melanoma (Melanoma, Malignant) 12/2015 - 10/2012
2	Fibrosis (Cirrhosis) 08/2013 - 10/2005
2	Virus Diseases (Viral Diseases) 01/2012 - 01/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2012 - 07/2006
2	Brain Neoplasms (Brain Tumor) 10/2010 - 06/2003
2	Wounds and Injuries (Trauma) 05/2009 - 03/2003
2	Lung Diseases (Lung Disease) 10/2005 - 02/2002
1	Chromothripsis 01/2022
1	Bites and Stings (Sting) 01/2022
1	Ischemia 01/2021

Drug/Important Bio-Agent (IBA)

60	AsbestosIBA 11/2021 - 02/2002
37	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2007
25	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2003
13	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 02/2002
11	HMGB1 Protein (HMG1)IBA 11/2021 - 07/2010
9	CytokinesIBA 09/2021 - 02/2005
9	EnzymesIBA 11/2019 - 10/2005
8	Biological ProductsIBA 01/2020 - 07/2004
8	MicroRNAs (MicroRNA)IBA 12/2019 - 03/2010
8	ImmunosorbentsIBA 10/2018 - 10/2005
8	Messenger RNA (mRNA)IBA 01/2018 - 06/2003
8	OsteopontinIBA 01/2016 - 10/2005
7	erioniteIBA 06/2017 - 01/2007
6	Protein Isoforms (Isoforms)IBA 01/2020 - 12/2008
6	Cisplatin (Platino)FDA LinkGeneric 08/2016 - 04/2004
5	Pharmaceutical PreparationsIBA 09/2021 - 04/2004
5	Crocidolite Asbestos (Blue Asbestos)IBA 01/2016 - 04/2005
5	MesothelinIBA 01/2016 - 04/2007
4	Mineral Fibers (Mineral Fiber)IBA 09/2021 - 12/2014
4	1-methyl-1-piperidinomethane sulfonateIBA 11/2015 - 02/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 04/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014 - 12/2010
3	CarcinogensIBA 01/2020 - 12/2004
3	Volatile Organic CompoundsIBA 01/2019 - 07/2008
3	Phosphotransferases (Kinase)IBA 01/2018 - 11/2011
3	InflammasomesIBA 01/2018 - 08/2013
3	Monoclonal AntibodiesIBA 09/2016 - 07/2012
3	Pemetrexed (MTA)FDA Link 05/2015 - 04/2004
3	Peptides (Polypeptides)IBA 09/2013 - 04/2007
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2011 - 02/2002
2	UbiquitinIBA 01/2022 - 08/2010
2	Oncogene Proteins (Oncogene Protein)IBA 12/2019 - 11/2017
2	Mitogen-Activated Protein Kinase 7IBA 01/2018 - 04/2013
2	Polysaccharides (Glycans)IBA 01/2018 - 01/2011
2	N 30IBA 01/2018 - 01/2008
2	Genetic Markers (Genetic Marker)IBA 11/2017 - 02/2005
2	Calbindin 2IBA 01/2017 - 09/2016
2	CAM 5.2 antigenIBA 01/2017 - 09/2016
2	Keratins (Keratin)IBA 01/2017 - 02/2004
2	AntigensIBA 03/2016 - 02/2002
2	AntibodiesIBA 03/2016 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 11/2011
2	VaccinesIBA 10/2015 - 02/2002
2	Aldehyde DehydrogenaseIBA 05/2015 - 01/2014
2	NucleotidesIBA 05/2015 - 09/2012
2	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 02/2002
2	Conditioned Culture MediaIBA 01/2015 - 06/2010
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2014 - 11/2009
2	VimentinIBA 01/2014 - 01/2014
2	CopperIBA 01/2014 - 08/2008
2	Blood Proteins (Serum Proteins)IBA 01/2014 - 12/2010
2	RNA (Ribonucleic Acid)IBA 09/2013 - 04/2009
2	integrin-linked kinaseIBA 05/2013 - 08/2011
2	AgarIBA 04/2013 - 04/2009
2	LuciferasesIBA 10/2012 - 05/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 07/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012 - 08/2010
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011 - 09/2011
2	MineralsIBA 08/2011 - 01/2007
2	Ribonucleases (Ribonuclease)IBA 05/2011 - 06/2008
2	ranpirnase (Pannon)IBA 05/2011 - 06/2008
2	SERPIN-B5 (maspin)IBA 04/2009 - 01/2006
1	InterferonsIBA 01/2022
1	Interferon Type IIBA 01/2022

Therapy/Procedure

32	Therapeutics 01/2022 - 03/2003
8	Radiotherapy 01/2022 - 12/2007
8	Drug Therapy (Chemotherapy) 11/2018 - 02/2006
7	Immunotherapy 01/2022 - 10/2012
5	Pneumonectomy (Lung Volume Reduction) 01/2018 - 03/2003
2	Operative Surgical Procedures 01/2019 - 06/2014
2	Adjuvant Chemotherapy 09/2017 - 12/2007
2	Injections 01/2014 - 07/2011